Biotechnology Stocks I Performance Guide: MoonLake Immunotherapeutics (MLTX)
MLTX has no dividends.
Table and Chart of MLTX Performance
See what a $1,000 investment in MLTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MLTX Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $10.40 |
| End Date | Oct-10-2024 |
| End Price | $47.00 |
| # Prices | 48 |
| Min Date | Jun-30-2022 |
| Min Price | $5.25 |
| Max Date | Jul-31-2023 |
| Max Price | $60.81 |
| Total Return | 351.92% |
| Annualized Return | 45.80% |
| Current Value of $1,000 Purchase | $4,519 |
| Number Returns | 1,128 |
| Average Return | 199.71% |
| Number Profitable Returns | 788 |
| Percent Profitable Returns | 69.86% |
| Number Unprofitable Returns | 340 |
| Percent Unprofitable Returns | 30.14% |
| Profitable to Unprofitable Returns Ratio | 2.32 |
| MLTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -41.530 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -78346824 |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $1.256 |
| 52 Week Low | $64.98 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $35.11 |
| 200-Day Moving Average | $48.42 |
| FINANCIAL DATA | |
| Revenue per Share | $-0.87 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -9.32% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MLTX Compare Returns with S&P 500
MLTX Trendline Chart
MLTX Moving Average Chart
MLTX Stock Return Map - See Patterns of Gains and Losses
MLTX Stock Returns/Purchase Dates